{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:57:29Z","timestamp":1792054649804,"version":"4.4.0"},"reference-count":268,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FOC"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:p>\n                    Meningiomas are mostly benign, slow-growing tumors of the CNS that originate from arachnoidal cap cells. While monosomy 22 is the most frequent genetic abnormality found in meningiomas, a multitude of other aberrant chromosomal alterations, signaling pathways, and growth factors have been implicated in its pathogenesis. Losses on 22q12.2, a region encoding the tumor suppressor gene\n                    <jats:italic>merlin<\/jats:italic>\n                    , represent the most common genetic alterations in early meningioma formation. Malignant meningioma progression, however, is associated with more complex karyotypes and greater genetic instability. Cytogenetic studies of atypical and anaplastic meningiomas revealed gains and losses on chromosomes 9, 10, 14, and 18, with amplifications on chromosome 17. However, the specific gene targets in a majority of these chromosomal abnormalities remain elusive.\n                  <\/jats:p>\n                  <jats:p>Studies have also implicated a myriad of aberrant signaling pathways involved with meningioma tumorigenesis, including those involved with proliferation, angiogenesis, and autocrine loops. Understanding these disrupted pathways will aid in deciphering the relationship between various genetic changes and their downstream effects on meningioma pathogenesis.<\/jats:p>\n                  <jats:p>Despite advancements in our understanding of meningioma pathogenesis, the conventional treatments, including surgery, radiotherapy, and stereotactic radiosurgery, have remained largely stagnant. Surgery and radiation therapy are curative in the majority of lesions, yet treatment remains challenging for meningiomas that are recurrent, aggressive, or refractory to conventional treatments. Future therapies will include combinations of targeted molecular agents as a result of continued progress in the understanding of genetic and biological changes associated with meningiomas.<\/jats:p>","DOI":"10.3171\/2011.2.focus1116","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T10:40:44Z","timestamp":1482835244000},"page":"E6","source":"Crossref","is-referenced-by-count":133,"title":["The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments"],"prefix":"10.3171","volume":"30","author":[{"given":"Winward","family":"Choy","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Stramotas","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Yew","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinton","family":"Gopen","sequence":"additional","affiliation":[{"name":"Division of Otolaryngology, University of California Los Angeles; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Parsa","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","article-title":"Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings","volume":"101","author":"Al-Mefty","year":"2004"},{"key":"b2-0300006","series-title":"Neoplasia","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1593\/neo.08356","article-title":"Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas","volume":"10","author":"Baia","year":"2008"},{"key":"b3-0300006","series-title":"Annu Rev Genomics Hum Genet","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.genom.3.022502.103031","article-title":"Hedgehog signaling and human disease","volume":"3","author":"Bale","year":"2002"},{"key":"b4-0300006","series-title":"Nature","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/25867","article-title":"p14ARF links the tumour suppressors RB and p53","volume":"395","author":"Bates","year":"1998"},{"key":"b5-0300006","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/jnnp.21.2.89","article-title":"The relapsing course of certain meningiomas in relation to pregnancy and menstruation","volume":"21","author":"Bickerstaff","year":"1958"},{"key":"b6-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3171\/jns.1997.87.3.0368","article-title":"The importance of pial blood supply to the development of peritumoral brain edema in meningiomas","volume":"87","author":"Bitzer","year":"1997"},{"key":"b7-0300006","series-title":"Can J Neurol Sci","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1017\/S0317167100032960","article-title":"Hormones, radiosurgery and virtual reality: new aspects of meningioma management","volume":"24","author":"Black","year":"1997"},{"key":"b8-0300006","series-title":"Endocr Rev","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1210\/er.2006-0046","article-title":"Notch signaling in development and cancer","volume":"28","author":"Bol\u00f3s","year":"2007"},{"key":"b9-0300006","series-title":"Am J Pathol","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","article-title":"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas","volume":"159","author":"Bostr\u00f6m","year":"2001"},{"key":"b10-0300006","series-title":"Dev Cell","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.devcel.2005.01.008","article-title":"Hedgehog signaling: from the Drosophila cuticle to anti-cancer drugs","volume":"8","author":"Briscoe","year":"2005"},{"key":"b11-0300006","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ijc.1219","article-title":"Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18","volume":"92","author":"B\u00fcschges","year":"2001"},{"key":"b12-0300006","series-title":"Brain Pathol","first-page":"145","article-title":"Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas","volume":"12","author":"B\u00fcschges","year":"2002"},{"key":"b13-0300006","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnen\/60.6.628","article-title":"Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications","volume":"60","author":"Cai","year":"2001"},{"key":"b14-0300006","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1128\/MCB.17.11.6265","article-title":"Neoplastic transformation by truncated alleles of human NOTCH1\/TAN1 and NOTCH2","volume":"17","author":"Capobianco","year":"1997"},{"key":"b15-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3171\/jns.1997.87.2.0315","article-title":"Expression and activation of epidermal growth factor receptors in meningiomas","volume":"87","author":"Carroll","year":"1997"},{"key":"b16-0300006","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1212\/01.WNL.0000118300.82017.F4","article-title":"Temozolomide for treatment-resistant recurrent meningioma","volume":"62","author":"Chamberlain","year":"2004"},{"key":"b17-0300006","series-title":"CA Cancer J Clin","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3322\/caac.20075","article-title":"Angiogenesis inhibitors: current strategies and future prospects","volume":"60","author":"Cook","year":"2010"},{"key":"b18-0300006","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1200\/JCO.2007.11.3985","article-title":"Antiangiogenics: the potential role of integrating this novel treatment modality with chemo-radiation for solid cancers","volume":"25","author":"Duda","year":"2007"},{"key":"b19-0300006","series-title":"Childs Nerv Syst","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00381-002-0562-7","article-title":"Telomerase in brain tumors","volume":"18","author":"Falchetti","year":"2002"},{"key":"b20-0300006","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1158\/0008-5472.CAN-05-1628","article-title":"Protein 4.1B\/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signaling","volume":"66","author":"Gerber","year":"2006"},{"key":"b21-0300006","series-title":"J Cell Sci","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1242\/jcs.112.6.895","article-title":"Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin","volume":"112","author":"Gr\u00f6nholm","year":"1999"},{"key":"b22-0300006","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007"},{"issue":"4","key":"b23-0300006","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/FOC-07\/10\/E9","article-title":"Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition","volume":"23","author":"Gupta","year":"2007"},{"key":"b24-0300006","series-title":"Hum Mol Genet","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/hmg\/10.14.1519","article-title":"Functional analysis of neurofibromatosis 2 (NF2) missense mutations","volume":"10","author":"Gutmann","year":"2001"},{"key":"b25-0300006","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1006\/nbdi.2000.0376","article-title":"The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion","volume":"8","author":"Gutmann","year":"2001"},{"key":"b26-0300006","series-title":"Hum Mol Genet","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/hmg\/8.2.267","article-title":"Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading","volume":"8","author":"Gutmann","year":"1999"},{"key":"b27-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1023\/A:1006365725033","article-title":"Expression of TGFalpha in meningiomas","volume":"45","author":"Halper","year":"1999"},{"key":"b28-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11060-010-0348-9","article-title":"A review of malignant meningiomas: diagnosis, characteristics, and treatment","volume":"99","author":"Hanft","year":"2010"},{"key":"b29-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3171\/jns.1996.84.5.0847","article-title":"Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma","volume":"84","author":"Harada","year":"1996"},{"key":"b30-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3171\/jns.1991.75.4.0564","article-title":"Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature","volume":"75","author":"Harrison","year":"1991"},{"key":"b31-0300006","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1056\/NEJMcibr0905857","article-title":"The hedgehog pathway and pancreatic cancer","volume":"361","author":"Hidalgo","year":"2009"},{"key":"b32-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3171\/jns.1997.86.1.0113","article-title":"Progesterone and estrogen receptors in meningiomas: prognostic considerations","volume":"86","author":"Hsu","year":"1997"},{"key":"b33-0300006","series-title":"Eur J Clin Invest","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1046\/j.1365-2362.2001.00892.x","article-title":"Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas","volume":"31","author":"Huang","year":"2001"},{"key":"b34-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3171\/jns.1999.91.1.0085","article-title":"Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer","volume":"91","author":"Ikeda","year":"1999"},{"key":"b35-0300006","series-title":"J Cell Physiol","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcp.10208","article-title":"HES and HERP families: multiple effectors of the Notch signaling pathway","volume":"194","author":"Iso","year":"2003"},{"key":"b36-0300006","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0090-3019(85)90180-6","article-title":"The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients","volume":"24","author":"J\u00e4\u00e4skel\u00e4inen","year":"1985"},{"key":"b37-0300006","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009"},{"key":"b38-0300006","series-title":"Biochem J","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/bj3560377","article-title":"The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association","volume":"356","author":"James","year":"2001"},{"key":"b39-0300006","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"33093","DOI":"10.1074\/jbc.M105792200","article-title":"Schwannomin isoform-1 interacts with syntenin via PDZ domains","volume":"276","author":"Jannatipour","year":"2001"},{"key":"b40-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3171\/jns.2003.99.5.0848","article-title":"Sex steroid hormone exposures and risk for meningioma","volume":"99","author":"Jhawar","year":"2003"},{"key":"b41-0300006","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ijc.1467","article-title":"Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas","volume":"94","author":"Joachim","year":"2001"},{"key":"b42-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3171\/jns.2001.94.2.0293","article-title":"Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells","volume":"94","author":"Johnson","year":"2001"},{"key":"b43-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1014588214966","article-title":"Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase","volume":"56","author":"Johnson","year":"2002"},{"key":"b44-0300006","series-title":"Cancer Biol Ther","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4161\/cbt.4.10.2184","article-title":"Hedgehog signaling pathway and gastric cancer","volume":"4","author":"Katoh","year":"2005"},{"key":"b45-0300006","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008"},{"key":"b46-0300006","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"30901","DOI":"10.1074\/jbc.M203563200","article-title":"Identification of Glis1, a novel Gli-related, Kruppel-like zinc finger protein containing transactivation and repressor functions","volume":"277","author":"Kim","year":"2002"},{"key":"b47-0300006","series-title":"Genes Cells","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2443.2001.00432.x","article-title":"Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma","volume":"6","author":"Kino","year":"2001"},{"key":"b48-0300006","series-title":"Histopathology","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2559.2003.01712.x","article-title":"Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival","volume":"43","author":"Konstantinidou","year":"2003"},{"key":"b49-0300006","series-title":"J Cell Sci","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1242\/jcs.115.6.1095","article-title":"Notch: a membrane-bound transcription factor","volume":"115","author":"Kopan","year":"2002"},{"key":"b50-0300006","series-title":"Development","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1242\/dev.02097","article-title":"Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation","volume":"132","author":"Koziel","year":"2005"},{"key":"b51-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1101\/gad.1054603","article-title":"NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions","volume":"17","author":"Lallemand","year":"2003"},{"key":"b52-0300006","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jnen\/63.4.275","article-title":"Meningioma pathology, genetics, and biology","volume":"63","author":"Lamszus","year":"2004"},{"key":"b53-0300006","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0165-4608(98)00209-X","article-title":"Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas","volume":"110","author":"Lamszus","year":"1999"},{"key":"b54-0300006","series-title":"Neurosurgery","first-page":"938","article-title":"Vascular endothelial growth factor, hepatocyte growth factor\/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy","volume":"46","author":"Lamszus","year":"2000"},{"key":"b55-0300006","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0046-8177(97)90029-0","article-title":"Telomerase activity in ordinary meningiomas predicts poor outcome","volume":"28","author":"Langford","year":"1997"},{"key":"b56-0300006","series-title":"Mol Med","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2119\/molmed.2010.00005","article-title":"Gene expression profiling of the hedgehog signaling pathway in human meningiomas","volume":"16","author":"Laurendeau","year":"2010"},{"key":"b57-0300006","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1038\/sj.onc.1202531","article-title":"NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas","volume":"18","author":"Leone","year":"1999"},{"key":"b58-0300006","series-title":"Adv Cancer Res","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0065-230X(08)60765-4","article-title":"Signal transduction through MAP kinase cascades","volume":"74","author":"Lewis","year":"1998"},{"key":"b59-0300006","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.humpath.2005.02.006","article-title":"Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas","volume":"36","author":"Liu","year":"2005"},{"key":"b60-0300006","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0165-4608(01)00430-7","article-title":"Analysis of p73 gene in meningiomas with deletion at 1p","volume":"129","author":"Lomas","year":"2001"},{"key":"b61-0300006","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/cncr.20036","article-title":"Dental x-rays and the risk of intracranial meningioma: a population-based case-control study","volume":"100","author":"Longstreth","year":"2004"},{"key":"b62-0300006","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0165-4608(03)00279-6","article-title":"Association of loss of 1p and alterations of chromosome 14 in meningioma progression","volume":"148","author":"Lopez-Gines","year":"2004"},{"key":"b63-0300006","series-title":"Neurocirugia (Astur)","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1130-1473(03)70510-7","article-title":"[Meningioma: a model of cytogenetic evolution in tumoral initiation and progresion.]","volume":"14","author":"L\u00f3pez-Gin\u00e9s","year":"2003"},{"key":"b64-0300006","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.humpath.2005.12.020","article-title":"Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study","volume":"37","author":"Loussouarn","year":"2006"},{"key":"b65-0300006","series-title":"Curr Opin Neurol","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/00019052-200412000-00008","article-title":"Meningioma: an update","volume":"17","author":"Lusis","year":"2004"},{"key":"b66-0300006","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1200\/JCO.2003.07.156","article-title":"New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology","volume":"21","author":"Maillo","year":"2003"},{"key":"b67-0300006","series-title":"Crit Rev Oncol Hematol","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","article-title":"Meningioma","volume":"67","author":"Marosi","year":"2008"},{"key":"b68-0300006","series-title":"Int J Mol Med","first-page":"771","article-title":"Mutational analysis of the DAL-1\/4.1B tumour-suppressor gene locus in meningiomas","volume":"16","author":"Martinez-Glez","year":"2005"},{"key":"b69-0300006","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0090-3019(03)00377-X","article-title":"Potential complications following radiotherapy for meningiomas","volume":"60","author":"Mathiesen","year":"2003"},{"key":"b70-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010"},{"key":"b71-0300006","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1158\/1078-0432.CCR-04-2550","article-title":"Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas","volume":"11","author":"Mawrin","year":"2005"},{"key":"b72-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1101\/gad.1335605","article-title":"Membrane organization and tumorigenesis\u2014the NF2 tumor suppressor, Merlin","volume":"19","author":"McClatchey","year":"2005"},{"key":"b73-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1101\/gad.12.8.1121","article-title":"Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly meta-static tumors","volume":"12","author":"McClatchey","year":"1998"},{"key":"b74-0300006","series-title":"Mol Carcinog","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/(SICI)1098-2744(199904)24:4<300::AID-MC8>3.0.CO;2-G","article-title":"Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32","volume":"24","author":"Mendiola","year":"1999"},{"key":"b75-0300006","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/sj.onc.1200853","article-title":"Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative \u2018tumor progression\u2019 locus","volume":"14","author":"Menon","year":"1997"},{"key":"b76-0300006","series-title":"Genes Chromosomes Cancer","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/gcc.2870130311","article-title":"Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas","volume":"13","author":"M\u00e9rel","year":"1995"},{"key":"b77-0300006","series-title":"Clin Cancer Res","first-page":"4435","article-title":"Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers","volume":"9","author":"Mihaila","year":"2003"},{"key":"b78-0300006","series-title":"Clin Cancer Res","first-page":"4443","article-title":"Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival","volume":"9","author":"Mihaila","year":"2003"},{"key":"b79-0300006","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1227\/01.NEU.0000170980.47582.A5","article-title":"Diagnosis and treatment of atypical and anaplastic meningiomas: a review","volume":"57","author":"Modha","year":"2005"},{"key":"b80-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44","volume":"15","author":"Morrison","year":"2001"},{"key":"b81-0300006","series-title":"J Clin Pathol","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jcp.57.1.6","article-title":"The eicosanoid cascade: possible role in gliomas and meningiomas","volume":"57","author":"Nathoo","year":"2004"},{"key":"b82-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-009-9948-7","article-title":"Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma","volume":"96","author":"Norden","year":"2010"},{"key":"b83-0300006","series-title":"Brain Pathol","first-page":"296","article-title":"p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade","volume":"11","author":"Nozaki","year":"2001"},{"key":"b84-0300006","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cancergencyto.2005.04.003","article-title":"Inactivation patterns of NF2 and DAL-1\/4.1B (EPB41L3) in sporadic meningioma","volume":"162","author":"Nunes","year":"2005"},{"key":"b85-0300006","series-title":"Mol Carcinog","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/mc.2940080203","article-title":"Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system","volume":"8","author":"Ohgaki","year":"1993"},{"key":"b86-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/A:1006086723607","article-title":"Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma","volume":"41","author":"Ozaki","year":"1999"},{"key":"b87-0300006","series-title":"J Exp Med","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles","volume":"183","author":"Pear","year":"1996"},{"key":"b88-0300006","series-title":"Brain Pathol","first-page":"183","article-title":"A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas","volume":"12","author":"Perry","year":"2002"},{"key":"b89-0300006","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/jnen\/59.10.872","article-title":"Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases","volume":"59","author":"Perry","year":"2000"},{"key":"b90-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11060-004-2749-0","article-title":"Molecular pathogenesis of meningiomas","volume":"70","author":"Perry","year":"2004"},{"key":"b91-0300006","series-title":"Neuropathol Appl Neurobiol","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2990.1998.00093.x","article-title":"Analysis of the PTEN gene in human meningiomas","volume":"24","author":"Peters","year":"1998"},{"issue":"4","key":"b92-0300006","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/FOC-07\/10\/E8","article-title":"Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas?","volume":"23","author":"Pfister","year":"2007"},{"key":"b93-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-010-0381-8","article-title":"Aberrant signaling pathways in meningiomas","volume":"99","author":"Ragel","year":"2010"},{"issue":"5","key":"b94-0300006","series-title":"Neurosurg Focus","first-page":"E9","article-title":"Molecular genetics of meningiomas","volume":"19","author":"Ragel","year":"2005"},{"issue":"4","key":"b95-0300006","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/FOC-07\/10\/E7","article-title":"Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors","volume":"23","author":"Ragel","year":"2007"},{"key":"b96-0300006","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/cncr.22441","article-title":"Celecoxib inhibits meningioma tumor growth in a mouse xenograft model","volume":"109","author":"Ragel","year":"2007"},{"key":"b97-0300006","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006"},{"key":"b98-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3171\/jns.1989.71.5.0665","article-title":"Incidence and clinicopathological features of meningioma","volume":"71","author":"Rohringer","year":"1989"},{"key":"b99-0300006","series-title":"Trends Cell Biol","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tcb.2007.06.007","article-title":"The Gli code: an information nexus regulating cell fate, stemness and cancer","volume":"17","author":"Ruiz i Altaba","year":"2007"},{"key":"b100-0300006","series-title":"Clin Cancer Res","first-page":"3749","article-title":"Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allyl-amino-17-demethoxygeldanamycin: a multitarget approach to radiosensitization","volume":"9","author":"Russell","year":"2003"},{"key":"b101-0300006","series-title":"Cancer Res","first-page":"1189","article-title":"Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors","volume":"55","author":"Samoto","year":"1995"},{"key":"b102-0300006","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s007010050462","article-title":"Biology of meningiomas","volume":"142","author":"Sanson","year":"2000"},{"key":"b103-0300006","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1054\/bjoc.2000.1583","article-title":"INI1 mutations in meningiomas at a potential hotspot in exon 9","volume":"84","author":"Schmitz","year":"2001"},{"key":"b104-0300006","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ng0498-354","article-title":"Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin","volume":"18","author":"Scoles","year":"1998"},{"key":"b105-0300006","series-title":"FASEB J","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995"},{"key":"b106-0300006","series-title":"Dev Cell","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","article-title":"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling","volume":"1","author":"Shaw","year":"2001"},{"key":"b107-0300006","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product","volume":"15","author":"Sherman","year":"1997"},{"key":"b108-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3171\/jns.2000.92.5.0832","article-title":"Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression","volume":"92","author":"Simon","year":"2000"},{"key":"b109-0300006","series-title":"Cancer Res","first-page":"4696","article-title":"Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression","volume":"55","author":"Simon","year":"1995"},{"key":"b110-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-010-0291-9","article-title":"Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas","volume":"102","author":"Skiriute","year":"2011"},{"key":"b111-0300006","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/sj.onc.1206623","article-title":"Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34","volume":"23","author":"Sulman","year":"2004"},{"key":"b112-0300006","series-title":"Neurosurgery","first-page":"1029","article-title":"Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients","volume":"49","author":"Stafford","year":"2001"},{"key":"b113-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1101\/gad.988902","article-title":"Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6\/E7 expression and late steps of malignant transformation","volume":"16","author":"Talora","year":"2002"},{"key":"b114-0300006","series-title":"APMIS","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1699-0463.1992.tb04002.x","article-title":"Expression of epidermal growth factor receptor in human meningiomas and meningeal tissue","volume":"100","author":"Torp","year":"1992"},{"key":"b115-0300006","series-title":"Cell","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"72","author":"Trofatter","year":"1993"},{"key":"b116-0300006","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0046-8177(97)90149-0","article-title":"Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas","volume":"28","author":"Tse","year":"1997"},{"key":"b117-0300006","series-title":"J Cell Biol","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1083\/jcb.126.2.391","article-title":"ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons","volume":"126","author":"Tsukita","year":"1994"},{"key":"b118-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1101\/gad.1693608","article-title":"Hedgehog: functions and mechanisms","volume":"22","author":"Varjosalo","year":"2008"},{"key":"b119-0300006","series-title":"Br J Neurosurg","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/02688699550041746","article-title":"The presence of progesterone receptors in arachnoid granulations and in the lining of arachnoid cysts: its relevance to expression of progesterone receptors in meningiomas","volume":"9","author":"Verhagen","year":"1995"},{"key":"b120-0300006","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/jnen\/59.6.544","article-title":"Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors","volume":"59","author":"von Deimling","year":"2000"},{"key":"b121-0300006","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ijc.2910640402","article-title":"Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction\/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples","volume":"64","author":"Wang","year":"1995"},{"key":"b122-0300006","series-title":"Curr Opin Cell Biol","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ceb.2007.02.005","article-title":"Shifting paradigms in Hedgehog signaling","volume":"19","author":"Wang","year":"2007"},{"key":"b123-0300006","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","article-title":"Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression","volume":"94","author":"Weber","year":"1997"},{"key":"b124-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11060-010-0349-8","article-title":"Medical therapies for meningiomas","volume":"99","author":"Wen","year":"2010"},{"key":"b125-0300006","series-title":"Neuro-oncol","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1215\/15228517-2009-010","article-title":"Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)","volume":"11","author":"Wen","year":"2009"},{"key":"b126-0300006","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1128\/MCB.25.6.2384-2394.2005","article-title":"The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression","volume":"25","author":"Xiao","year":"2005"},{"key":"b127-0300006","series-title":"J Neurosci Res","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7","article-title":"Merlin differentially associates with the microtubule and actin cytoskeleton","volume":"51","author":"Xu","year":"1998"},{"key":"b128-0300006","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/1097-0142(20000901)89:5<1102::AID-CNCR20>3.0.CO;2-L","article-title":"Recurrence of meningiomas","volume":"89","author":"Yamasaki","year":"2000"},{"issue":"Suppl 1","key":"b129-0300006","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1054\/jocn.2001.0877","article-title":"Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas","volume":"8","author":"Yang","year":"2001"},{"key":"b130-0300006","series-title":"Biochem J","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1042\/bj20020060","article-title":"The 4.1\/ezrin\/radixin\/moesin domain of the DAL-1\/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins","volume":"365","author":"Yu","year":"2002"},{"key":"b131-0300006","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1073\/pnas.92.14.6414","article-title":"Alterations in Notch signaling in neoplastic lesions of the human cervix","volume":"92","author":"Zagouras","year":"1995"},{"key":"b132-0300006","series-title":"Cytogenet Cell Genet","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000056986","article-title":"Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases","volume":"93","author":"Zang","year":"2001"},{"key":"b133-0300006","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccr.2005.06.004","article-title":"Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling","volume":"8","author":"Zeng","year":"2005"},{"key":"b134-0300006","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","article-title":"Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression","volume":"70","author":"Zhang","year":"2010"},{"key":"b1-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","article-title":"Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings","volume":"101","author":"Al-Mefty","year":"2004"},{"key":"b2-0300006","series-title":"Neoplasia","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1593\/neo.08356","article-title":"Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas","volume":"10","author":"Baia","year":"2008"},{"key":"b3-0300006","series-title":"Annu Rev Genomics Hum Genet","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.genom.3.022502.103031","article-title":"Hedgehog signaling and human disease","volume":"3","author":"Bale","year":"2002"},{"key":"b4-0300006","series-title":"Nature","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/25867","article-title":"p14ARF links the tumour suppressors RB and p53","volume":"395","author":"Bates","year":"1998"},{"key":"b5-0300006","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/jnnp.21.2.89","article-title":"The relapsing course of certain meningiomas in relation to pregnancy and menstruation","volume":"21","author":"Bickerstaff","year":"1958"},{"key":"b6-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3171\/jns.1997.87.3.0368","article-title":"The importance of pial blood supply to the development of peritumoral brain edema in meningiomas","volume":"87","author":"Bitzer","year":"1997"},{"key":"b7-0300006","series-title":"Can J Neurol Sci","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1017\/S0317167100032960","article-title":"Hormones, radiosurgery and virtual reality: new aspects of meningioma management","volume":"24","author":"Black","year":"1997"},{"key":"b8-0300006","series-title":"Endocr Rev","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1210\/er.2006-0046","article-title":"Notch signaling in development and cancer","volume":"28","author":"Bol\u00f3s","year":"2007"},{"key":"b9-0300006","series-title":"Am J Pathol","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","article-title":"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas","volume":"159","author":"Bostr\u00f6m","year":"2001"},{"key":"b10-0300006","series-title":"Dev Cell","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.devcel.2005.01.008","article-title":"Hedgehog signaling: from the Drosophila cuticle to anti-cancer drugs","volume":"8","author":"Briscoe","year":"2005"},{"key":"b11-0300006","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ijc.1219","article-title":"Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18","volume":"92","author":"B\u00fcschges","year":"2001"},{"key":"b12-0300006","series-title":"Brain Pathol","first-page":"145","article-title":"Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas","volume":"12","author":"B\u00fcschges","year":"2002"},{"key":"b13-0300006","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnen\/60.6.628","article-title":"Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications","volume":"60","author":"Cai","year":"2001"},{"key":"b14-0300006","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1128\/MCB.17.11.6265","article-title":"Neoplastic transformation by truncated alleles of human NOTCH1\/TAN1 and NOTCH2","volume":"17","author":"Capobianco","year":"1997"},{"key":"b15-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3171\/jns.1997.87.2.0315","article-title":"Expression and activation of epidermal growth factor receptors in meningiomas","volume":"87","author":"Carroll","year":"1997"},{"key":"b16-0300006","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1212\/01.WNL.0000118300.82017.F4","article-title":"Temozolomide for treatment-resistant recurrent meningioma","volume":"62","author":"Chamberlain","year":"2004"},{"key":"b17-0300006","series-title":"CA Cancer J Clin","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3322\/caac.20075","article-title":"Angiogenesis inhibitors: current strategies and future prospects","volume":"60","author":"Cook","year":"2010"},{"key":"b18-0300006","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1200\/JCO.2007.11.3985","article-title":"Antiangiogenics: the potential role of integrating this novel treatment modality with chemo-radiation for solid cancers","volume":"25","author":"Duda","year":"2007"},{"key":"b19-0300006","series-title":"Childs Nerv Syst","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00381-002-0562-7","article-title":"Telomerase in brain tumors","volume":"18","author":"Falchetti","year":"2002"},{"key":"b20-0300006","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1158\/0008-5472.CAN-05-1628","article-title":"Protein 4.1B\/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signaling","volume":"66","author":"Gerber","year":"2006"},{"key":"b21-0300006","series-title":"J Cell Sci","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1242\/jcs.112.6.895","article-title":"Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin","volume":"112","author":"Gr\u00f6nholm","year":"1999"},{"key":"b22-0300006","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007"},{"issue":"4","key":"b23-0300006","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/FOC-07\/10\/E9","article-title":"Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition","volume":"23","author":"Gupta","year":"2007"},{"key":"b24-0300006","series-title":"Hum Mol Genet","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/hmg\/10.14.1519","article-title":"Functional analysis of neurofibromatosis 2 (NF2) missense mutations","volume":"10","author":"Gutmann","year":"2001"},{"key":"b25-0300006","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1006\/nbdi.2000.0376","article-title":"The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion","volume":"8","author":"Gutmann","year":"2001"},{"key":"b26-0300006","series-title":"Hum Mol Genet","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/hmg\/8.2.267","article-title":"Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading","volume":"8","author":"Gutmann","year":"1999"},{"key":"b27-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1023\/A:1006365725033","article-title":"Expression of TGFalpha in meningiomas","volume":"45","author":"Halper","year":"1999"},{"key":"b28-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11060-010-0348-9","article-title":"A review of malignant meningiomas: diagnosis, characteristics, and treatment","volume":"99","author":"Hanft","year":"2010"},{"key":"b29-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3171\/jns.1996.84.5.0847","article-title":"Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma","volume":"84","author":"Harada","year":"1996"},{"key":"b30-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3171\/jns.1991.75.4.0564","article-title":"Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature","volume":"75","author":"Harrison","year":"1991"},{"key":"b31-0300006","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1056\/NEJMcibr0905857","article-title":"The hedgehog pathway and pancreatic cancer","volume":"361","author":"Hidalgo","year":"2009"},{"key":"b32-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3171\/jns.1997.86.1.0113","article-title":"Progesterone and estrogen receptors in meningiomas: prognostic considerations","volume":"86","author":"Hsu","year":"1997"},{"key":"b33-0300006","series-title":"Eur J Clin Invest","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1046\/j.1365-2362.2001.00892.x","article-title":"Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas","volume":"31","author":"Huang","year":"2001"},{"key":"b34-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3171\/jns.1999.91.1.0085","article-title":"Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer","volume":"91","author":"Ikeda","year":"1999"},{"key":"b35-0300006","series-title":"J Cell Physiol","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcp.10208","article-title":"HES and HERP families: multiple effectors of the Notch signaling pathway","volume":"194","author":"Iso","year":"2003"},{"key":"b36-0300006","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0090-3019(85)90180-6","article-title":"The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients","volume":"24","author":"J\u00e4\u00e4skel\u00e4inen","year":"1985"},{"key":"b37-0300006","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009"},{"key":"b38-0300006","series-title":"Biochem J","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/bj3560377","article-title":"The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association","volume":"356","author":"James","year":"2001"},{"key":"b39-0300006","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"33093","DOI":"10.1074\/jbc.M105792200","article-title":"Schwannomin isoform-1 interacts with syntenin via PDZ domains","volume":"276","author":"Jannatipour","year":"2001"},{"key":"b40-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3171\/jns.2003.99.5.0848","article-title":"Sex steroid hormone exposures and risk for meningioma","volume":"99","author":"Jhawar","year":"2003"},{"key":"b41-0300006","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ijc.1467","article-title":"Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas","volume":"94","author":"Joachim","year":"2001"},{"key":"b42-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3171\/jns.2001.94.2.0293","article-title":"Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells","volume":"94","author":"Johnson","year":"2001"},{"key":"b43-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1014588214966","article-title":"Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase","volume":"56","author":"Johnson","year":"2002"},{"key":"b44-0300006","series-title":"Cancer Biol Ther","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4161\/cbt.4.10.2184","article-title":"Hedgehog signaling pathway and gastric cancer","volume":"4","author":"Katoh","year":"2005"},{"key":"b45-0300006","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008"},{"key":"b46-0300006","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"30901","DOI":"10.1074\/jbc.M203563200","article-title":"Identification of Glis1, a novel Gli-related, Kruppel-like zinc finger protein containing transactivation and repressor functions","volume":"277","author":"Kim","year":"2002"},{"key":"b47-0300006","series-title":"Genes Cells","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2443.2001.00432.x","article-title":"Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma","volume":"6","author":"Kino","year":"2001"},{"key":"b48-0300006","series-title":"Histopathology","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2559.2003.01712.x","article-title":"Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival","volume":"43","author":"Konstantinidou","year":"2003"},{"key":"b49-0300006","series-title":"J Cell Sci","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1242\/jcs.115.6.1095","article-title":"Notch: a membrane-bound transcription factor","volume":"115","author":"Kopan","year":"2002"},{"key":"b50-0300006","series-title":"Development","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1242\/dev.02097","article-title":"Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation","volume":"132","author":"Koziel","year":"2005"},{"key":"b51-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1101\/gad.1054603","article-title":"NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions","volume":"17","author":"Lallemand","year":"2003"},{"key":"b52-0300006","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jnen\/63.4.275","article-title":"Meningioma pathology, genetics, and biology","volume":"63","author":"Lamszus","year":"2004"},{"key":"b53-0300006","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0165-4608(98)00209-X","article-title":"Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas","volume":"110","author":"Lamszus","year":"1999"},{"key":"b54-0300006","series-title":"Neurosurgery","first-page":"938","article-title":"Vascular endothelial growth factor, hepatocyte growth factor\/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy","volume":"46","author":"Lamszus","year":"2000"},{"key":"b55-0300006","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0046-8177(97)90029-0","article-title":"Telomerase activity in ordinary meningiomas predicts poor outcome","volume":"28","author":"Langford","year":"1997"},{"key":"b56-0300006","series-title":"Mol Med","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2119\/molmed.2010.00005","article-title":"Gene expression profiling of the hedgehog signaling pathway in human meningiomas","volume":"16","author":"Laurendeau","year":"2010"},{"key":"b57-0300006","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1038\/sj.onc.1202531","article-title":"NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas","volume":"18","author":"Leone","year":"1999"},{"key":"b58-0300006","series-title":"Adv Cancer Res","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0065-230X(08)60765-4","article-title":"Signal transduction through MAP kinase cascades","volume":"74","author":"Lewis","year":"1998"},{"key":"b59-0300006","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.humpath.2005.02.006","article-title":"Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas","volume":"36","author":"Liu","year":"2005"},{"key":"b60-0300006","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0165-4608(01)00430-7","article-title":"Analysis of p73 gene in meningiomas with deletion at 1p","volume":"129","author":"Lomas","year":"2001"},{"key":"b61-0300006","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/cncr.20036","article-title":"Dental x-rays and the risk of intracranial meningioma: a population-based case-control study","volume":"100","author":"Longstreth","year":"2004"},{"key":"b62-0300006","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0165-4608(03)00279-6","article-title":"Association of loss of 1p and alterations of chromosome 14 in meningioma progression","volume":"148","author":"Lopez-Gines","year":"2004"},{"key":"b63-0300006","series-title":"Neurocirugia (Astur)","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1130-1473(03)70510-7","article-title":"[Meningioma: a model of cytogenetic evolution in tumoral initiation and progresion.]","volume":"14","author":"L\u00f3pez-Gin\u00e9s","year":"2003"},{"key":"b64-0300006","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.humpath.2005.12.020","article-title":"Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study","volume":"37","author":"Loussouarn","year":"2006"},{"key":"b65-0300006","series-title":"Curr Opin Neurol","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/00019052-200412000-00008","article-title":"Meningioma: an update","volume":"17","author":"Lusis","year":"2004"},{"key":"b66-0300006","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1200\/JCO.2003.07.156","article-title":"New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology","volume":"21","author":"Maillo","year":"2003"},{"key":"b67-0300006","series-title":"Crit Rev Oncol Hematol","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","article-title":"Meningioma","volume":"67","author":"Marosi","year":"2008"},{"key":"b68-0300006","series-title":"Int J Mol Med","first-page":"771","article-title":"Mutational analysis of the DAL-1\/4.1B tumour-suppressor gene locus in meningiomas","volume":"16","author":"Martinez-Glez","year":"2005"},{"key":"b69-0300006","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0090-3019(03)00377-X","article-title":"Potential complications following radiotherapy for meningiomas","volume":"60","author":"Mathiesen","year":"2003"},{"key":"b70-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010"},{"key":"b71-0300006","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1158\/1078-0432.CCR-04-2550","article-title":"Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas","volume":"11","author":"Mawrin","year":"2005"},{"key":"b72-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1101\/gad.1335605","article-title":"Membrane organization and tumorigenesis\u2014the NF2 tumor suppressor, Merlin","volume":"19","author":"McClatchey","year":"2005"},{"key":"b73-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1101\/gad.12.8.1121","article-title":"Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly meta-static tumors","volume":"12","author":"McClatchey","year":"1998"},{"key":"b74-0300006","series-title":"Mol Carcinog","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/(SICI)1098-2744(199904)24:4<300::AID-MC8>3.0.CO;2-G","article-title":"Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32","volume":"24","author":"Mendiola","year":"1999"},{"key":"b75-0300006","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/sj.onc.1200853","article-title":"Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative \u2018tumor progression\u2019 locus","volume":"14","author":"Menon","year":"1997"},{"key":"b76-0300006","series-title":"Genes Chromosomes Cancer","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/gcc.2870130311","article-title":"Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas","volume":"13","author":"M\u00e9rel","year":"1995"},{"key":"b77-0300006","series-title":"Clin Cancer Res","first-page":"4435","article-title":"Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers","volume":"9","author":"Mihaila","year":"2003"},{"key":"b78-0300006","series-title":"Clin Cancer Res","first-page":"4443","article-title":"Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival","volume":"9","author":"Mihaila","year":"2003"},{"key":"b79-0300006","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1227\/01.NEU.0000170980.47582.A5","article-title":"Diagnosis and treatment of atypical and anaplastic meningiomas: a review","volume":"57","author":"Modha","year":"2005"},{"key":"b80-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44","volume":"15","author":"Morrison","year":"2001"},{"key":"b81-0300006","series-title":"J Clin Pathol","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jcp.57.1.6","article-title":"The eicosanoid cascade: possible role in gliomas and meningiomas","volume":"57","author":"Nathoo","year":"2004"},{"key":"b82-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11060-009-9948-7","article-title":"Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma","volume":"96","author":"Norden","year":"2010"},{"key":"b83-0300006","series-title":"Brain Pathol","first-page":"296","article-title":"p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade","volume":"11","author":"Nozaki","year":"2001"},{"key":"b84-0300006","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cancergencyto.2005.04.003","article-title":"Inactivation patterns of NF2 and DAL-1\/4.1B (EPB41L3) in sporadic meningioma","volume":"162","author":"Nunes","year":"2005"},{"key":"b85-0300006","series-title":"Mol Carcinog","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/mc.2940080203","article-title":"Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system","volume":"8","author":"Ohgaki","year":"1993"},{"key":"b86-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/A:1006086723607","article-title":"Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma","volume":"41","author":"Ozaki","year":"1999"},{"key":"b87-0300006","series-title":"J Exp Med","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles","volume":"183","author":"Pear","year":"1996"},{"key":"b88-0300006","series-title":"Brain Pathol","first-page":"183","article-title":"A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas","volume":"12","author":"Perry","year":"2002"},{"key":"b89-0300006","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/jnen\/59.10.872","article-title":"Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases","volume":"59","author":"Perry","year":"2000"},{"key":"b90-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11060-004-2749-0","article-title":"Molecular pathogenesis of meningiomas","volume":"70","author":"Perry","year":"2004"},{"key":"b91-0300006","series-title":"Neuropathol Appl Neurobiol","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2990.1998.00093.x","article-title":"Analysis of the PTEN gene in human meningiomas","volume":"24","author":"Peters","year":"1998"},{"issue":"4","key":"b92-0300006","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/FOC-07\/10\/E8","article-title":"Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas?","volume":"23","author":"Pfister","year":"2007"},{"key":"b93-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-010-0381-8","article-title":"Aberrant signaling pathways in meningiomas","volume":"99","author":"Ragel","year":"2010"},{"issue":"5","key":"b94-0300006","series-title":"Neurosurg Focus","first-page":"E9","article-title":"Molecular genetics of meningiomas","volume":"19","author":"Ragel","year":"2005"},{"issue":"4","key":"b95-0300006","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/FOC-07\/10\/E7","article-title":"Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors","volume":"23","author":"Ragel","year":"2007"},{"key":"b96-0300006","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/cncr.22441","article-title":"Celecoxib inhibits meningioma tumor growth in a mouse xenograft model","volume":"109","author":"Ragel","year":"2007"},{"key":"b97-0300006","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006"},{"key":"b98-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3171\/jns.1989.71.5.0665","article-title":"Incidence and clinicopathological features of meningioma","volume":"71","author":"Rohringer","year":"1989"},{"key":"b99-0300006","series-title":"Trends Cell Biol","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tcb.2007.06.007","article-title":"The Gli code: an information nexus regulating cell fate, stemness and cancer","volume":"17","author":"Ruiz i Altaba","year":"2007"},{"key":"b100-0300006","series-title":"Clin Cancer Res","first-page":"3749","article-title":"Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allyl-amino-17-demethoxygeldanamycin: a multitarget approach to radiosensitization","volume":"9","author":"Russell","year":"2003"},{"key":"b101-0300006","series-title":"Cancer Res","first-page":"1189","article-title":"Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors","volume":"55","author":"Samoto","year":"1995"},{"key":"b102-0300006","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s007010050462","article-title":"Biology of meningiomas","volume":"142","author":"Sanson","year":"2000"},{"key":"b103-0300006","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1054\/bjoc.2000.1583","article-title":"INI1 mutations in meningiomas at a potential hotspot in exon 9","volume":"84","author":"Schmitz","year":"2001"},{"key":"b104-0300006","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ng0498-354","article-title":"Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin","volume":"18","author":"Scoles","year":"1998"},{"key":"b105-0300006","series-title":"FASEB J","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995"},{"key":"b106-0300006","series-title":"Dev Cell","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","article-title":"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling","volume":"1","author":"Shaw","year":"2001"},{"key":"b107-0300006","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product","volume":"15","author":"Sherman","year":"1997"},{"key":"b108-0300006","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3171\/jns.2000.92.5.0832","article-title":"Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression","volume":"92","author":"Simon","year":"2000"},{"key":"b109-0300006","series-title":"Cancer Res","first-page":"4696","article-title":"Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression","volume":"55","author":"Simon","year":"1995"},{"key":"b110-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-010-0291-9","article-title":"Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas","volume":"102","author":"Skiriute","year":"2011"},{"key":"b111-0300006","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/sj.onc.1206623","article-title":"Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34","volume":"23","author":"Sulman","year":"2004"},{"key":"b112-0300006","series-title":"Neurosurgery","first-page":"1029","article-title":"Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients","volume":"49","author":"Stafford","year":"2001"},{"key":"b113-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1101\/gad.988902","article-title":"Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6\/E7 expression and late steps of malignant transformation","volume":"16","author":"Talora","year":"2002"},{"key":"b114-0300006","series-title":"APMIS","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1699-0463.1992.tb04002.x","article-title":"Expression of epidermal growth factor receptor in human meningiomas and meningeal tissue","volume":"100","author":"Torp","year":"1992"},{"key":"b115-0300006","series-title":"Cell","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"72","author":"Trofatter","year":"1993"},{"key":"b116-0300006","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0046-8177(97)90149-0","article-title":"Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas","volume":"28","author":"Tse","year":"1997"},{"key":"b117-0300006","series-title":"J Cell Biol","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1083\/jcb.126.2.391","article-title":"ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons","volume":"126","author":"Tsukita","year":"1994"},{"key":"b118-0300006","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1101\/gad.1693608","article-title":"Hedgehog: functions and mechanisms","volume":"22","author":"Varjosalo","year":"2008"},{"key":"b119-0300006","series-title":"Br J Neurosurg","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/02688699550041746","article-title":"The presence of progesterone receptors in arachnoid granulations and in the lining of arachnoid cysts: its relevance to expression of progesterone receptors in meningiomas","volume":"9","author":"Verhagen","year":"1995"},{"key":"b120-0300006","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/jnen\/59.6.544","article-title":"Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors","volume":"59","author":"von Deimling","year":"2000"},{"key":"b121-0300006","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ijc.2910640402","article-title":"Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction\/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples","volume":"64","author":"Wang","year":"1995"},{"key":"b122-0300006","series-title":"Curr Opin Cell Biol","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ceb.2007.02.005","article-title":"Shifting paradigms in Hedgehog signaling","volume":"19","author":"Wang","year":"2007"},{"key":"b123-0300006","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","article-title":"Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression","volume":"94","author":"Weber","year":"1997"},{"key":"b124-0300006","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11060-010-0349-8","article-title":"Medical therapies for meningiomas","volume":"99","author":"Wen","year":"2010"},{"key":"b125-0300006","series-title":"Neuro-oncol","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1215\/15228517-2009-010","article-title":"Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)","volume":"11","author":"Wen","year":"2009"},{"key":"b126-0300006","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1128\/MCB.25.6.2384-2394.2005","article-title":"The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression","volume":"25","author":"Xiao","year":"2005"},{"key":"b127-0300006","series-title":"J Neurosci Res","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7","article-title":"Merlin differentially associates with the microtubule and actin cytoskeleton","volume":"51","author":"Xu","year":"1998"},{"key":"b128-0300006","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/1097-0142(20000901)89:5<1102::AID-CNCR20>3.0.CO;2-L","article-title":"Recurrence of meningiomas","volume":"89","author":"Yamasaki","year":"2000"},{"issue":"Suppl 1","key":"b129-0300006","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1054\/jocn.2001.0877","article-title":"Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas","volume":"8","author":"Yang","year":"2001"},{"key":"b130-0300006","series-title":"Biochem J","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1042\/bj20020060","article-title":"The 4.1\/ezrin\/radixin\/moesin domain of the DAL-1\/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins","volume":"365","author":"Yu","year":"2002"},{"key":"b131-0300006","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1073\/pnas.92.14.6414","article-title":"Alterations in Notch signaling in neoplastic lesions of the human cervix","volume":"92","author":"Zagouras","year":"1995"},{"key":"b132-0300006","series-title":"Cytogenet Cell Genet","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000056986","article-title":"Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases","volume":"93","author":"Zang","year":"2001"},{"key":"b133-0300006","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccr.2005.06.004","article-title":"Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling","volume":"8","author":"Zeng","year":"2005"},{"key":"b134-0300006","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","article-title":"Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression","volume":"70","author":"Zhang","year":"2010"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/30\/5\/2011.2.focus1116.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/30\/5\/2011.2.focus1116.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/30\/5\/2011.2.focus1116.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:47:19Z","timestamp":1780130839000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/30\/5\/2011.2.focus1116.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":268,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2011.2.focus1116","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}